Hence, the mayo staging system (2004) for light chain amyloidosis adopted the of use serum levels of cardiac troponins (that is, troponin T[cTnT] or I) as well as brain natriuretic peptide (BNP) and its N-terminal propeptide 7. Here, TNNT2 is linked to AL amyloidosis.